Literature DB >> 3278751

Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation.

L F Verdonck1, G C de Gast, J M Lange, H J Schuurman, A W Dekker, B J Bast.   

Abstract

A 22-year-old man who underwent syngeneic bone marrow transplantation (BMT) for acute lymphoblastic leukemia acquired a human immunodeficiency virus (HIV) infection by transfusion of blood products from a donor at risk. The manifestations were acute encephalopathy together with immune thrombocytopenia in the early posttransplant period, and acquired immunodeficiency syndrome (AIDS) developed 20 months after BMT. Because he had a syngeneic donor, the possibility of reconstituting the immune system was investigated by repeated transfer of healthy syngeneic lymphocytes and by combining repeated transfer of syngeneic lymphocytes with the antiviral agent suramin to protect the infused leukocytes from being attacked by HIV. No improvement was observed clinically or in the patient's immune functions by these efforts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278751

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Authors:  Ann E Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

Review 2.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.

Authors:  G Hütter; J A Zaia
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

Review 3.  HIV cure strategies: which ones are appropriate for Africa?

Authors:  Christopher Zaab-Yen Abana; Helena Lamptey; Evelyn Y Bonney; George B Kyei
Journal:  Cell Mol Life Sci       Date:  2022-07-06       Impact factor: 9.207

Review 4.  Hematopoietic stem cell transplantation for HIV cure.

Authors:  Daniel R Kuritzkes
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

5.  Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.

Authors:  Christine Johnston; Robert Harrington; Rupali Jain; Joshua Schiffer; Hans-Peter Kiem; Ann Woolfrey
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-08       Impact factor: 5.742

6.  Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor.

Authors:  R LaPushin; K Totpal; M Higuchi; B B Aggarwal
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

Review 7.  Stem cell transplantation in strategies for curing HIV/AIDS.

Authors:  Gero Hütter
Journal:  AIDS Res Ther       Date:  2016-09-13       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.